Search

James R Goldenring

from Nashville, TN
Age ~66
Get Report
Related to:
Thomas HerzbergJames T Herzberg, 69Jessica Goldenring, 30Katee Goldenring, 28Kate Goldenring, 27Kate Goldenring
Connected to:
Alex M Goldenstein, 38Bette K Goldenring, 96Gene J Goldenstein, 79Gina S Goldensher, 54Igor Goldenshteyn, 55Jami L Goldenstein, 61Michelle Goldenshteyn, 41Claudia S Goldenthal, 71Deborah Goldenthal, 72Jessica C Goldenthal, 49

James Goldenring Phones & Addresses

  • 4301 Dakota Ave, Nashville, TN 37209 (615) 386-6777
  • 4833 Redcastle Rdg, Nashville, TN 37211 (615) 332-7507
  • 3492 Rhodes Hill Ct, Martinez, GA 30907 (706) 855-8128
  • 3761 Lake Ave, Augusta, GA 30907 (706) 855-8128
  • Scottsdale, AZ
  • New Haven, CT
  • Columbus, GA
  • 4301 Dakota Ave, Nashville, TN 37209 (615) 500-9564

Work

Position: Food Preparation and Serving Related Occupations

Education

School / High School: Yale University 1986

Languages

English

Specialities

General Surgery

Professional Records

Medicine Doctors

James Goldenring Photo 1

Dr. James R Goldenring, Nashville TN - MD (Doctor of Medicine)

View page
Specialties:
General Surgery
Address:
1310 24Th Ave S, Nashville, TN 37212
(615) 936-3726 (Phone)
Languages:
English
Education:
Medical School
Yale University
Graduated: 1986
James Goldenring Photo 2

James R. Goldenring

View page
Specialties:
General Surgery
Work:
Vanderbilt Ingram Cancer Center Medical Oncology
2220 Pierce Ave 777 Prb, Nashville, TN 37232
(615) 936-8580 (phone), (615) 343-7602 (fax)
Languages:
English
Description:
Dr. Goldenring works in Nashville, TN and specializes in General Surgery. Dr. Goldenring is affiliated with Vanderbilt University Medical Center.
James Goldenring Photo 3

James Goldenring, Nashville TN

View page
Specialties:
Clinical Pharmacology
General Practice
Surgery
Work:
Tennessee Valley Healthcare System
1310 24Th Ave S, Nashville, TN 37212
Education:
Yale University (1986)
James Goldenring Photo 4

James Richard Goldenring, Nashville TN

View page
Specialties:
Family Physician
Address:
1310 24Th Ave S, Nashville, TN 37212

Business Records

Name / Title
Company / Classification
Phones & Addresses
James Richard Goldenring
James Goldenring MD,PHD
Surgeons · Family Doctor
1310 24 Ave S, Nashville, TN 37212
(615) 936-3726

Publications

Us Patents

Screen For Gastric Adenocarcinoma

View page
US Patent:
6372439, Apr 16, 2002
Filed:
Oct 1, 1998
Appl. No.:
09/164954
Inventors:
James R. Goldenring - Martinez GA, 30907
P. Henry Schmidt - Augusta GA, 30909
Jeffrey R. Lee - Martinez GA, 30907
International Classification:
G01N 3353
US Classification:
435 71, 435 4, 435 72, 435 723
Abstract:
It has been determined that a specific metaplastie lineage that contains immunoreactivity for a trefoil polypeptide, spasmolytic peptide, is associated with and gives rise to the vast majority of human adenocarcinomas. The identification of this Spasmolytic Polypeptide Expressing Metaplasia (SPEM) is a major factor for grading of biopsies of the stomach to assess risk for gastric cancer. It also forms the basis of a method for serological screening for those at risk for gastric cancer. In a preferred embodiment, antibodies to spasmolytic peptide (hSP) are used in immunostaining of biopsies of gastric tissue obtained by endoscopy for grading biopsies Those patients having these cells, characterized by a morphology more typical of a type of cell present normally in the intestine and not stomach, Brunners gland cells, are at risk of developing adenocarinoma. Since these cells express hSP, antibodies or nucleic acid probes hybridizing to mRNA encoding hSP, can be used for rapid detection of the cells in tissue biopsies. The antibodies can also be used in serological tests for screening and following patients at risk for gastric cancer.

Screen For Risk For Gastric Adenocarcinoma

View page
US Patent:
6773890, Aug 10, 2004
Filed:
Jan 29, 2002
Appl. No.:
10/060113
Inventors:
James R. Goldenring - Nashville TN
P. Henry Schmidt - Augusta GA
Jeffrey R. Lee - Martinez GA
Assignee:
Medical College of Georgia Research Institute, Inc. - Augusta GA
International Classification:
G01N 3353
US Classification:
435 71, 435810, 5303871
Abstract:
It has been determined that a specific metaplastic lineage that contains immunoreactivity for a trefoil polypeptide, spasmolytic peptide, is associated with and gives rise to the vast majority of human adenocarcinomas. The identification of this Spasmolytic Polypeptide Expressing Metaplasia (SPEM) is a major factor for grading of biopsies of the stomach to assess risk for gastric cancer. It also forms the basis of a method for serological screening for those at risk for gastric cancer. In a preferred embodiment, antibodies to spasmolytic peptide (hSP) are used in immunostaining of biopsies of gastric tissue obtained by endoscopy for grading biopsies. Those patients having these cells, characterized by a morphology more typical of a type of cell present normally in the intestine and not stomach, Brunners gland cells, are at risk of developing adenocarcinoma. Since these cells express hSP, antibodies or nucleic acid probes hybridizing to mRNA encoding hSP, can be used for rapid detection of the cells in tissue biopsies. The antibodies can also be used in serological tests for screening and following patients at risk for gastric cancer.

Methods Of Screening For Gastrointestinal Cancer

View page
US Patent:
7811778, Oct 12, 2010
Filed:
Sep 5, 2007
Appl. No.:
11/850555
Inventors:
James R. Goldenring - Nashville TN, US
Assignee:
Vanderbilt University - Nashiville TN
International Classification:
G01N 33/574
US Classification:
435 723, 435 71, 435 6
Abstract:
Methods for diagnosing an upper gastrointestinal (GI) cancer in a subject by determining an amount of one or more biomarkers in a biological sample from the subject are provided. Methods for determining whether to initiate or continue prophylaxis or treatment of an upper GI cancer in a subject by determining any measurable change in the amounts of the at least one biomarker in each of a series of biological samples provided over a time period are also provided.

Methods Of Screening For Gastric Cancer

View page
US Patent:
20110059452, Mar 10, 2011
Filed:
Aug 18, 2010
Appl. No.:
12/858846
Inventors:
James R. Goldenring - Nashville TN, US
Ki Taek Nam - Franklin TN, US
Hyuk-Joon Lee - Seoul, KR
Han-Kwang Yang - Seoul, KR
Woo Ho Kim - Seoul, KR
International Classification:
C12Q 1/68
G01N 33/574
US Classification:
435 6, 435 71
Abstract:
Method and systems are provided for diagnosing or monitoring a gastric cancer in a subject. Such methods include providing a biological sample from the subject; determining an amount in the sample of at least one biomarker, selected from the group consisting of: CDH17 and OLFM4; and comparing the amount of the at least one biomarker in the sample, if present, to a control level of the at least one biomarker. Such systems include a probe for selectively binding each of at least one biomarker.

Method Of Detecting And Grading Dysplasia In Epithelial Tissue

View page
US Patent:
61070483, Aug 22, 2000
Filed:
Nov 20, 1997
Appl. No.:
8/974692
Inventors:
James R. Goldenring - Martinez GA
Gregory S. Ray - Snellville GA
Jeffrey R. Lee - Martinez GA
Assignee:
Medical College of Georgia Research Institute, Inc. - Augusta GA
International Classification:
G01N 3353
C07K 1600
C12Q 168
US Classification:
435 71
Abstract:
A method of detecting dysplastic regions within epithelial tissue samples is sensitive enough to detect and distinguish between low grade and high grade dysplastic regions. The method uses probes specific for expression and accumulation of substances within a particular intracellular region from a defect in apical membrane trafficking (trafficking markers) and in the preferred embodiment correlates the trafficking marker levels with the presence of an oncogene such as p53. If low grade dysplasia is present, trafficking markers are detected in a distinctive perinuclear pattern. Previous studies have demonstrated a high correlation of p53 over-expression with high grade dysplasia and adenocarcinoma. Detection of p53 is shown to be mutually exclusive of detection of trafficking markers. Therefore, dual detection for both the trafficking markers and p53 provides an accurate method for more precise grading of biopsies.
Control profile
James R Goldenring from Nashville, TN, age ~66 Get Report